Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

30 oct. 2014 08h30 HE | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals to Present on Liposome Delivery Systems at 2014 American Association of Pharmaceutical Scientists Annual Meeting

EWING, N.J., Oct. 30, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a biopharmaceutical company that is transforming the science of combination therapy and developing products...
28 oct. 2014 10h48 HE | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Completion of Its Public Offering and the Exercise in Full of Option to Purchase Additional Units of Common Stock and Warrants to Purchase Common Stock

EWING, N.J., Oct. 28, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a biopharmaceutical company that is transforming the science of combination therapy and developing products...
27 oct. 2014 08h30 HE | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Phase 3 Clinical Study of CPX-351 Achieved Target Enrollment in High Risk (Secondary) Acute Myeloid Leukemia

EWING, N.J., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a biopharmaceutical company that is transforming the science of combination therapy and developing products...
23 oct. 2014 07h00 HE | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Pricing of a $12.9 Million Public Offering of Common Stock and Warrants to Purchase Common Stock

EWING, N.J., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the...
17 oct. 2014 12h57 HE | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Public Offering of Common Stock and Warrants to Purchase Common Stock

EWING, N.J., Oct. 17, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
19 sept. 2014 08h30 HE | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals to Present at BioCentury's 21st Annual NewsMakers in the Biotech Industry Conference

EWING, N.J., Sept. 19, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
17 sept. 2014 08h30 HE | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals to Ring the NASDAQ Stock Market Closing Bell on September 17, 2014

EWING, N.J., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
15 sept. 2014 08h30 HE | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Publication of Preclinical Data for CPX-351 in Acute Lymphoblastic Leukemia Models

EWING, N.J., Sept. 15, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the...
03 sept. 2014 08h30 HE | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Appointment of Michael Dougherty as Chairman of the Board

EWING, N.J., Sept. 3, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the...
02 sept. 2014 08h30 HE | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals to Present at Rodman & Renshaw 16th Annual Global Investment Conference

EWING, N.J., Sept. 2, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...

Page suivante